research use only
Cat.No.S8005
| Related Targets | EGFR JAK STAT |
|---|---|
| Other Pim Inhibitors | SGI-1776 free base AZD1208 PIM447 (LGH447) Hydrochloride CX-6258 HCl Uzansertib (INCB053914) TP-3654 Hispidulin SMI-16a TCS PIM-1 1 Quercetagetin |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| human PC3 cells | Proliferation assay | 48 h | Antiproliferative activity against human PC3 cells after 48 hrs by MTS assay, IC50=17 μM | |||
| DLD-1 cell | Function assay | 96 h | Inhibition of growth of DLD-1 cell line after 96 hours of exposure time with the compound dissolved in DMSO, IC50=17.8 μM | |||
| HT-29 cell | Function assay | Inhibition of growth of HT-29 cell line after 72+72 hours of exposure time with the compound dissolved in DMSO, IC50=31.4 μM | ||||
| HCT116 cell | Function assay | 72 h | Inhibition of growth of HCT116 cell line after 72 hours of exposure time with the compound dissolved in DMSO, IC50=48.8 μM | |||
| HEK293T cells | Function assay | 0.5 μM | 1 h | Inhibition of human recombinant Flag-Pim1 autophosphorylation expressed in HEK293T cells labeled with [32PO4] at 0.5 uM after 1hr by Western blotting | ||
| Click to View More Cell Line Experimental Data | ||||||
| Molecular Weight | 273.23 | Formula | C11H6F3NO2S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 438190-29-5 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | TCS PIM-1 4a | Smiles | C1=CC(=CC(=C1)C(F)(F)F)C=C2C(=O)NC(=O)S2 | ||
|
In vitro |
DMSO
: 55 mg/mL
(201.29 mM)
Ethanol : 23 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Features |
SMI-4a (5μM) synergizes with rapamycin (5 nM) to cause significant growth inhibition of leukemic cells.
|
|---|---|
| Targets/IC50/Ki |
Pim1
(Cell-free assay) 17 nM
|
| In vitro |
SMI-4a is an ATP competitive inhibitor of Pim1 with IC50 of 17 nM. This compound shows high selectivity for Pim1 against a panel of kinases. It inhibits the in vitro phosphorylation by Pim-1 of the known substrate, the translational repressor 4E-BP1. This chemical (5μM) inhibits pancreatic and leukemic cells growth. It reduces phosphorylation of the Pim target Bad in prostate and hematopoietic cells. This compound causes cell cycle arrest and reverses the antiapoptotic activity of Pim-1. It increases the amount of p27Kip1 in the nucleus. Its treatment of pre-T-LBL inhibits the mTOR pathway. This compound reduces MYC protein expression in pre-T-LBL. Its treatment induces up-regulation of MAPK pathway.
|
| In vivo |
SMI-4a (60 mg/Kg) treatment twice daily significantly reduce tumour size and is well tolerated. Tumours harvested 1 hour after the final oral gavage of this compound demonstrates decreased phosphorylation of p70 S6K compared with tumours from mice treated with vehicle, whereas in comparison total p70 S6K expression is unchanged.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.